People: Dicerna Pharmaceuticals Inc (DRNA.OQ)
12.01USD
20 Apr 2018
-- (--)
$12.01
--
--
--
--
124,250
$14.99
$2.69
Halak, Brian
Dr. Brian K. Halak, Ph.D., is Independent Director of Dicerna Pharmaceuticals Inc. Dr. Halak has served as a member of our board of directors since August 2010. Dr. Halak is currently a partner of Domain Associates, LLC, which he joined in 2001. Prior to joining Domain Associates, LLC, Dr. Halak was an associate with Advanced Technology Ventures. Prior to that, Dr. Halak was a consultant at the Wilkerson Group. Dr. Halak currently serves as a member of the boards of directors of Alimera Sciences, Inc. (NASDAQ: ALIM), BioNano Genomics, Inc., Carticept Medical, Inc., Corridor Pharmaceuticals, Inc., Domain Elite, Kona Medical, Inc. and Oraya Therapeutics Inc. He previously served on the boards of directors of Eddingpharm, Esprit Pharma, Inc. (acquired by Allergan, Inc.), GI Dynamics, Inc. (ASX: GID) and Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA). Dr. Halak received his BSE in bioengineering from the University of Pennsylvania and his Ph.D. in immunology from the Thomas Jefferson University. We believe that Dr. Halak’s experience in the venture capital industry, particularly with biopharmaceutical companies, and his experience serving on the boards of directors of a number of biopharmaceutical companies provide him with the qualifications and skills to serve as a member of our board of directors.
Basic Compensation
Total Annual Compensation, | -- |
Restricted Stock Award, | -- |
Long-Term Incentive Plans, | -- |
All Other, | -- |
Fiscal Year Total, | -- |
Options Compensation
Quantity | Market Value | |
---|---|---|
Exercisable | -- | -- |
Unexercisable | -- | -- |
Exercised | -- | -- |
Name | Fiscal Year Total |
---|---|
David Madden |
-- |
Douglas Fambrough |
5,288,440 |
John Green |
-- |
Bob Brown |
2,158,630 |
Theodore Ashburn |
-- |
Pankaj Bhargava |
2,968,670 |